Login / Signup

Impact of suppressing ciprofloxacin susceptibility results on antibiotic utilization and hospital-acquired Clostridioides difficile infection.

Bryan P WhiteDaniel B ChastainKaren K KinneyKatie ThompsonJerry KelleyCindy B McCloskey
Published in: Antimicrobial stewardship & healthcare epidemiology : ASHE (2021)
Keyphrases
  • clostridium difficile
  • pseudomonas aeruginosa
  • healthcare
  • signaling pathway
  • acute care
  • adverse drug
  • cystic fibrosis